# Safety and Efficacy of Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 Years

> **NCT07485543** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** BMD003 (CFTR mRNA)

## Key facts

- **NCT ID:** NCT07485543
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07485543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07485543, "Safety and Efficacy of Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 Years". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07485543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*